dr. wang on addition of acalabrutinib to bendamustine/rituximab in mcl
Published 4 years ago • 169 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
0:54
dr. wang on updated data with single-agent acalabrutinib in mcl
-
1:06
dr. phillips on the safety of acalabrutinib plus bendamustine/rituximab in mcl
-
1:14
rationale for combining acalabrutinib with bendamustine and rituximab in mcl
-
1:51
safety and efficacy findings for acalabrutinib plus bendamustine and rituximab in mcl
-
2:20
dr. wang on acalabrutinib activity in mantle cell lymphoma
-
1:20
dr. wang discusses single-agent acalabrutinib in mcl
-
0:55
dr. wang on the evolution of treatment in mcl
-
0:58
dr. wang discusses acalabrutinib in mcl
-
0:51
dr. wang on precision medicine in mcl
-
1:19
dr. wang on triplet vorinostat regimen in newly diagnosed mcl
-
0:47
dr. wang on the safety profile of kte-x19 in mcl
-
1:01
dr. wang on future research with car t-cell therapy in mcl
-
1:58
dr. wang on car t-cell therapy resistance in mcl
-
1:15
dr. wang on the pace of progress in mcl
-
1:29
dr. wang on the benefit of btk inhibitors in mcl
-
1:51
dr. wang on research trends in mcl
-
1:03
dr. wang discusses promise of venetoclax in mcl
-
1:57
dr. wang on combatting car t-cell therapy resistance in mcl
-
2:07
dr. wang discusses the treatment of relapsed/refractory mcl